Keywords: انسولین پایه; Basal insulin; Insulin initiation; Type 2 diabetes mellitus; Physician perceptions; Blood glucose monitoring;
مقالات ISI انسولین پایه (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: انسولین پایه; basal insulin; GLP-1 receptor agonist; type 2 diabetes mellitus; real-world;
Keywords: انسولین پایه; basal insulin; hypoglycemia; management; type 2 diabetes;
Keywords: انسولین پایه; Sulfonylurea; Biguanide; Thiazolidinedione (TZD); Dipeptidyl peptidase (DPP)-4 inhibitor; Sodium glucose cotransporter (SGLT)-2 inhibitor; Glucagon-like peptide (GLP)-1 receptor agonist; Basal insulin; Prandial insulin;
Keywords: انسولین پایه; Basal insulin; Glycemic targets; Type 2 diabetes; Goal achievements; Physician survey; Real-world evidence;
Keywords: انسولین پایه; basal insulin; elderly; glycemic control; insulin glargine; type 2 diabetes
Keywords: انسولین پایه; Diabetes mellitus; Insulina basal; Análogo de insulina; Insulina degludec; Insulina glarginaDiabetes mellitus; Basal insulin; Insulin analogue; Insulin degludec; Insulin glargine
Keywords: انسولین پایه; Insulin treatment; Glycemic goals; Insulin titration; Basal insulin; Insulin initiation; type 2 diabetes mellitus;
Keywords: انسولین پایه; Insulin initiation; Type 2 diabetes; Persistence; Basal insulin; Primary care;
Keywords: انسولین پایه; Basal insulin; Insulin; Type 2 diabetes
Keywords: انسولین پایه; Nursing home; long term care; inpatient hyperglycemia; sliding scale insulin; basal insulin; hospital hyperglycemia;
A Randomized Controlled Study Comparing a DPP4 Inhibitor (Linagliptin) and Basal Insulin (Glargine) in Patients With Type 2 Diabetes in Long-term Care and Skilled Nursing Facilities: Linagliptin-LTC Trial
Keywords: انسولین پایه; Incretin; DPP4 inhibitors; long-term care; nursing home; skilled nursing facilities; glargine; linagliptin; basal insulin; hospital hyperglycemia; older adults; diabetes;
Switching to insulin glargine 300 U/mL: Is duration of prior basal insulin therapy important?
Keywords: انسولین پایه; Basal insulin; Duration of insulin therapy; Insulin glargine; Type 2 diabetes mellitus;
Expanded Basal Insulin Options for Type 2 Diabetes Mellitus
Keywords: انسولین پایه; basal insulin; concentrated insulin; insulin degludec; insulin glargine; U-500 insulin;
Safety and efficacy of a basal-plus regimen with insulin glargine and insulin glulisine for elderly patients with high cardiovascular risk and type 2 diabetes mellitus
Keywords: انسولین پایه; Diabetes mellitus; Basal insulin; Basal-plus; Insulinisation; Elderly patients; Diabetes mellitus; Insulina basal; Basal plus; Insulinización; Pacientes ancianos;
Addition of once daily prandial lixisenatide to basal insulin therapy in patients with type-2 diabetes results in a reduction of HbA1c as an effect of postprandial glucose lowering
Keywords: انسولین پایه; Glucagon-like peptide-1 receptor agonists; Basal insulin; Postprandial glucose; Body weight; Hypoglycaemia;
Basal Insulin Regimens for Adults with Type 1 Diabetes Mellitus: A Cost-Utility Analysis
Keywords: انسولین پایه; basal insulin; CUA; NICE; type 1 diabetes;
Factors associated with reaching or not reaching target HbA1c after initiation of basal or premixed insulin in patients with type 2 diabetes
Keywords: انسولین پایه; Basal insulin; HbA1c quartiles; Premixed insulin; Target HbA1c; Type 2 diabetes; ADA; American Diabetes Association; AUC; area under the curve; EASD; European Association for the Study of Diabetes; FHG; fasting hyperglycaemia; FPG; fasting plasma glucose;
Basal insulin treatment intensification in patients with type 2 diabetes mellitus: A comprehensive systematic review of current options
Keywords: انسولین پایه; Basal insulin; Treatment intensification; Type 2 diabetes mellitus; 4P-MACE; 4-point major adverse cardiovascular events; ADA; American Diabetes Association; AE; adverse event; AUC; area under the glucose curve; BID; twice daily; BMI; body mass index; CHF
Injectable insulin-lysozyme-loaded nanogels with enzymatically-controlled degradation and release for basal insulin treatment: In vitro characterization and in vivo observation
Keywords: انسولین پایه; Nanomaterials; Injectable gels; Self-assembly; Basal insulin; Diabetes; Amphiphilic chitosan;
New insulin types in type 1 diabetes mellitus
Keywords: انسولین پایه; Diabetes mellitus; Basal insulin; Insulin analogue; Insulin degludec; Insulin glargineDiabetes mellitus; Insulina basal; Análogo de insulina; Insulina degludec; Insulina glargina
Insulin Degludec, a Long-Acting Once-Daily Basal Analogue for Type 1 and Type 2 Diabetes Mellitus
Keywords: انسولین پایه; basal insulin; degludec; insulin analogue; insulin injector; nocturnal hypoglycemia; type 1 diabetes; type 2 diabetesinsuline basale; dégludec; analogue de l’insuline; injecteur d’insuline; hypoglycémie nocturne; diabète de type 1; diabète de type 2
Individualizing treatment of type 2 diabetes by targeting postprandial or fasting hyperglycaemia: Response to a basal vs a premixed insulin regimen by HbA1c quartiles and ethnicity
Keywords: انسولین پایه; Basal insulin; Ethnicity; HbA1c; Premixed insulin; Type 2 diabetes
Perspectives pour améliorer la prise en charge des patients diabétiques de type 2 sous insuline
Keywords: انسولین پایه; Diabète de type 2; Insulinothérapie; Parcours de soins; Ãducation thérapeutique; Observance; Insuline basale; Hypoglycémies; Nouvelles technologies; Type 2 diabetes; Insulin therapy; Care course; Patient education; Observance; Basal insulin; Hypoglyc
ReviewNew Insulins and New Aspects in Insulin Delivery
Keywords: انسولین پایه; basal insulin; degludec; diabetes; glargine U300; pegylated lispro; insuline basale; degludec; diabète; glargine U300; pégylé lispro;
Programme L&Vous : premiers enseignements de l'Observatoire National de l'Utilisation, en vie réelle, de l'Insuline Basale par les patients diabétiques de Type 2
Keywords: انسولین پایه; Diabète de type 2; insulinothérapie basale; bon usage; optimisation; charte; observatoire; vraie vie; Type 2 diabetes; basal insulin; good use; optimization; charter; observatory; real life;
GLP-1 RAs as compared to prandial insulin after failure of basal insulin in type 2 diabetes: lessons from the 4B and Get-Goal DUO 2 trials
Keywords: انسولین پایه; GLP-1 receptor agonists; exenatide; lixisenatide; basal insulin
Options for intensification of basal insulin in type 2 diabetes: Premeal insulin or short-acting GLP-1 receptor agonists?
Keywords: انسولین پایه; GLP-1 receptor agonists; Postprandial hyperglycaemia; Basal insulin; Premeal insulin
Once-daily prandial lixisenatide versus once-daily rapid-acting insulin in patients with type 2 diabetes mellitus insufficiently controlled with basal insulin: analysis of data from five randomized, controlled trials
Keywords: انسولین پایه; Lixisenatide; Basal insulin; Basal + RAI; GLP-1 receptor agonist;
Lixisenatide plus basal insulin in patients with type 2 diabetes mellitus: a meta-analysis
Keywords: انسولین پایه; Lixisenatide; Combination; Basal insulin; Prandial; Meta-analysis;
Programme « L&Vous » : élaboration d'une charte de bonne utilisation de l'insuline basale chez le patient diabétique de type 2
Keywords: انسولین پایه; Diabète de type 2; insulinothérapie basale; bon usage; optimisation; élaboration de charte; Type 2 diabetes; basal insulin; good use; optimization; charter's implementation;
Efficacité et tolérance de l'insuline dégludec dans le diabète de type 1 et de type 2 : résultats des essais cliniques de phase IIIa
Keywords: انسولین پایه; Insuline dégludec; insuline basale; hypoglycémie; flexibilité; hypoglycémie nocturne; Insulin degludec; basal insulin; hypoglycemia; flexibility; nocturnal hypoglycemia;
Differences in inpatient glycemic control and response to subcutaneous insulin therapy between medicine and surgery patients with type 2 diabetesâ
Keywords: انسولین پایه; Type 2 diabetes; Medicine and surgery patients; Inpatient hyperglycemia; Glargine; Glulisine; Sliding scale insulin; Basal insulin; Hospital hyperglycemia;
Initiating Basal Insulin Therapy in Type 2 Diabetes: Practical Steps to Optimize Glycemic Control
Keywords: انسولین پایه; Basal insulin; Insulin detemir; Insulin glargine
Comparaison pharmacodynamique d'un analogue lent de l'insuline et d'un débit de base unique délivré par pompe lors de l'épreuve de jeûne de l'insulinothérapie fonctionnelle
Keywords: انسولین پایه; Diabète de type 1; insuline basale; variabilité glycémique; insulinothérapie fonctionnelle; mesure continue du glucose; Type 1 diabetes; basal insulin; glycemic variability; functional insulin therapy; continuous glucose monitoring;
Direct healthcare costs of patients with type 2 diabetes using long-acting insulin analogues or NPH insulin in a basal insulin-only regimen
Keywords: انسولین پایه; Basal insulin; Insulin analogues; Direct healthcare costs; Denmark
Lower fasting blood glucose, glucose variability and nocturnal hypoglycaemia with glargine vs NPH basal insulin in subjects with Type 1 diabetes
Keywords: انسولین پایه; Basal insulin; Insulin analogues; Glargine; Intensive therapy
Insulinización basal y enfermedad aterosclerótica en la diabetes mellitus tipo 2
Keywords: انسولین پایه; Diabetes mellitus tipo 2; Insulinización basal; Insulina glarginaType 2 diabetes mellitus; Basal insulin; Glargine insulin
Initiating and Intensifying Insulin Therapy in Type 2 Diabetes Mellitus
Keywords: انسولین پایه; Basal Insulin; Insulin; Insulin Initiation; Insulin Intensification; Premix Insulin; Type 2 Diabetes Mellitus;
pI-shifted insulin analogs with extended in vivo time action and favorable receptor selectivity
Keywords: انسولین پایه; Basal insulin; Blood glucose control; Receptor selectivity